Clinical aspects and comorbidities of psoriasis

Journal of Rheumatology

Volumn 36, Issue SUPPL. 83, 2009, Pages 19-20

  Ayala, Fabio ^a   Ayala, Fabrizio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular disease; Diabetes; Hypertension; Metabolic Syndrome; Obesity; Psoriasis

Indexed keywords

ABDOMINAL OBESITY; ANXIETY DISORDER; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONFERENCE PAPER; CORONARY ARTERY; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; STROKE; SYSTEMIC DISEASE; TH1 CELL; TH17 CELL; ARTICLE; IMMUNOLOGY; OBESITY;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY;

EID: 70349934447     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090214     Document Type: Conference Paper

References (15)

1. Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL) 17 and IL-22 modulate distinct inflammatory and keratinocyte response pathways. Br J Dermatol 2008;159:1092-1102
2. Griffiths CEM, Christophers E, Barker JNWN, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007;156:258-262 (Pubitemid 46095952)
3. Ayala F. Clinical presentation of psoriasis. Reumatismo 2007;59 Suppl:40-45
4. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007;25:529-534
5. Scarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006;33:210-212
6. de Corte J, Sprangers MAG, Mombers FMC, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol Symp Proc 2004;9:140-147 (Pubitemid 38457272)
7. Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031-1042
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:141-228
9. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005;25:2243-2244
10. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-1741 (Pubitemid 44547793)
11. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-411 (Pubitemid 40220344)
12. Sterry W, Strober BE,Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic inplications. Report of an interdisciplinary conference and review. Br J Dermatol 2007;157:649-655
13. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005;141:1527-1534 (Pubitemid 41815842)
14. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008;159:342-350 (Pubitemid 352009847)
15. Naldi L, Addis A, Chimenti S, et al. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Dermatology 2008;217:365-373